nodepositbonuscasino2023|卫信康：子公司获得门冬氨酸钾注射液药品注册证书

News summary

Wei Xinkang: The subsidiary obtained the drug registration certificate for potassium aspartate injection. Securities Times e Company Newsnodepositbonuscasino2023, Wei Xinkang (603676) announced on the evening of May 5 that recently, Yangpu Jingtai Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received approval and issuance from the State Food and Drug Administrationnodepositbonuscasino2023Potassium aspartate injectionnodepositbonuscasino2023.nodepositbonuscasino2023..

Newsletter text

Wei Xinkang: The subsidiary obtained the drug registration certificate for potassium aspartate injection. Securities Times e Company News, Wei Xinkang (603676) announced on the evening of May 5 that recently, Yangpu Jingtai Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the "Drug Registration Certificate" for potassium aspartate injection approved and issued by the State Food and Drug Administration. Potassium aspartate injection is an electrolyte supplement used for hypokalemia caused by various reasons.